---
schema_version: "secwatch.filing_event.v1"
accession: "0001739104-25-000011"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:50:07.427403+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elanco Q4 adjusted EPS $0.14, revenue $1.02B; FY 2025 guidance reflects FX headwinds

## Summary
- Q4 2024 revenue $1,020M (-1% reported, +4% organic CC); adjusted EPS $0.14 (vs $0.08); adjusted EBITDA $177M (17.4% margin).
- FY 2024 revenue $4,439M (flat reported, +3% organic CC); adjusted EPS $0.91 (vs $0.89); innovation revenue $461M (beat target).
- FY 2025 guidance: revenue $4,445-4,510M; adjusted EPS $0.80-0.86; adjusted EBITDA $830-870M; mid-single-digit organic CC growth.
- 2025 innovation revenue target raised to $640-720M; net leverage 4.3x; expects FX headwind of $110M to revenue, $45M to EBITDA.
- Q1 2025 guidance: revenue $1,155-1,180M; adjusted EPS $0.29-0.34; adjusted EBITDA $240-260M.

## SEC filing metadata
- accession: 0001739104-25-000011
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000011/0001739104-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000011/elan-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001739104-25-000011
- JSON: https://secwatch.observer/filing/0001739104-25-000011.json
- Plain text: https://secwatch.observer/filing/0001739104-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.